Chagas disease: modulation of the inflammatory response by acetylcholinesterase in hematological cells and brain

Aniélen D Silva1, Nathieli B Bottari1, Guilherme M do Carmo1

  • 1Department of Biochemistry and Molecular Biology, Universidade Federal de Santa Maria (UFSM), Santa Maria, RS, Brazil.

Insights

Chagas disease infection in mice alters acetylcholinesterase activity and acetylcholine levels, activating the anti-inflammatory cholinergic pathway in the central nervous system.

Area of Science:

  • Neuroimmunology
  • Parasitology
  • Pharmacology

Background:

  • Chagas disease, caused by *Trypanosoma cruzi*, triggers severe inflammation.
  • The inflammatory cholinergic pathway, regulated by acetylcholinesterase, influences acetylcholine levels, an anti-inflammatory mediator.
  • Understanding the interplay between *T. cruzi* infection and this pathway is crucial for managing Chagas disease.

Purpose of the Study:

  • To investigate the impact of *Trypanosoma cruzi* infection on acetylcholinesterase activity and acetylcholine levels in mice.
  • To determine if these alterations are linked to the inflammatory cholinergic signaling pathway during acute Chagas disease.

Main Methods:

  • Mice were infected with *T. cruzi* (Y strain) and compared to uninfected controls.
  • Acetylcholinesterase activity, acetylcholine, and nitric oxide levels were measured in blood, lymphocytes, and brain.
  • Myeloperoxidase activity and brain histopathology were analyzed to assess inflammation.

Main Results:

  • Acetylcholinesterase activity decreased in blood and brain but increased in lymphocytes post-infection.
  • *T. cruzi* infection elevated acetylcholine and nitric oxide levels in the brain.
  • Increased myeloperoxidase activity and histopathological damage indicated heightened neuroinflammation.

Conclusions:

  • Acute Chagas disease in mice induces significant alterations in the cholinergic system.
  • Neuroinflammation in the central nervous system activates the anti-inflammatory cholinergic pathway.
  • This study highlights the complex neuroimmune response during Chagas disease.

Related Concept Videos

Indirect-Acting Cholinergic Agonists: Pharmacological Actions01:30

Indirect-Acting Cholinergic Agonists: Pharmacological Actions

Indirect-acting cholinergic agonists, also known as anticholinesterases, exert their pharmacological effects by enhancing cholinergic transmission in various body parts, including the neuromuscular junction, autonomic cholinergic synapses, and the brain.
At the neuromuscular junction, these agents work by inhibiting the breakdown of acetylcholine, allowing it to remain bound to the receptor and bind to nearby receptors. This process leads to repetitive firing of the endplate, causing muscle...
1.7K
Parasympathetic Signaling01:30

Parasympathetic Signaling

Parasympathetic signaling plays a crucial role in regulating various physiological processes. It involves the release of acetylcholine (ACh) by parasympathetic neurons, which can have localized and short-lived effects. The majority of ACh released is rapidly inactivated at the synapse by the enzyme acetylcholinesterase (AChE), which hydrolyzes Ach into choline and acetate. Additionally, the tissue cholinesterase deactivates any ACh diffusing into the surrounding tissues.
The effects of...
3.5K
Inflammatory Response01:28

Inflammatory Response

An inflammatory response is a localized, nonspecific immune reaction that occurs when a tissue is injured. It is characterized by redness, swelling, heat, and pain, which are commonly called the cardinal signs and symptoms of inflammation. Inflammation can sometimes result in a loss of function.
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
17.5K
Cholinergic Receptors: Muscarinic01:25

Cholinergic Receptors: Muscarinic

The pharmacological actions of acetylcholine are elicited via its binding to two families of cholinergic receptors or cholinoceptors, namely, muscarinic and nicotinic receptors. Muscarinic receptors are G protein-coupled receptors and have five subtypes, M1–M5. All mAChR subtypes are activated by acetylcholine and blocked by the antagonist, atropine. 
The subtypes M1, M3, and M5 couple with the Gq subunit and activate the phospholipase C (PLC) activity, mobilizing intracellular Ca2+....
5.5K
Anticholinesterase Agents: Poisoning and Treatment01:26

Anticholinesterase Agents: Poisoning and Treatment

Anticholinesterases, also known as cholinesterase inhibitors, work by blocking the breakdown of acetylcholine, leading to its accumulation in the synaptic cleft. This accumulation indirectly enhances both muscarinic and nicotinic actions. These agents are classified as reversible or irreversible based on their mechanism of action.     
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is...
1.8K
Cholinesterases: Distribution and Function01:22

Cholinesterases: Distribution and Function

Cholinesterases are a group of serine hydrolase enzymes that play a crucial role in the breakdown of choline esters. The two primary types of cholinesterases are acetylcholinesterases (AChEs) and butyrylcholinesterase (BuChEs), which differ in their distribution, function, and substrate specificity. AChEs, also known as true cholinesterases, specifically hydrolyze acetylcholine, while BuChEs, often referred to as pseudocholinesterases, can hydrolyze various choline esters, including...
1.1K